title: Pharmacologic evaluation of the discriminative stimulus of metachlorophenylpiperazine.
abstract: A pharmacologic analysis of the discriminative stimulus of metachlorophenylpiperazine (mCPP) is reported. mCPP and m-trifluoromethylphenylpiperazine generalised, whereas 5-methoxy-3-(1,2,3,6-tetrahydro-4-pyridinyl)-1H-indole, 6-chloro-2-(1-piperazinyl)-pyrazine, and mesulergine partially generalised to the mCPP discriminative cue. However, although mianserin, methiothepin, ritanserin, mesulergine and N-(1-methyl-5'-indolyl)-N'-(3-pyridyl)urea hydrochloride (SB 200646) all antagonised the effect of 5-hydroxytryptamine (5-HT) on IP3 formation in the rat choroid plexus, they failed to antagonise the mCPP response in the drug discrimination studies. The 5-HT3 receptor antagonist MDL 72222 neither generalised nor antagonised the mCPP cue. These data suggest that neither the 5-HT1A, 5-HT1B, 5-HT1D, 5-HT2A, 5-HT2B, 5-HT2C, 5-HT3, 5-HT5, 5-HT6, nor 5-HT7 receptors are involved. The response does appear to be mediated by a postsynaptic 5-HT receptor, however, because fenfluramine generalised to the cue. Haloperidol generalises, and amphetamine partially antagonises the mCPP discriminative cue and low doses of apomorphine partially generalises to the mCPP cue, which suggests that a decrease in dopamine neurotransmission may also be involved.
authors.affiliation: Pharma Division, F. Hoffmann-La Roche Ltd, Switzerland.
authors.forename: A
authors.initials: A
authors.lastname: Bourson
authors.forename: D
authors.initials: D
authors.lastname: Wanner
authors.forename: R
authors.initials: R
authors.lastname: Wyler
authors.forename: N
authors.initials: N
authors.lastname: Petit
authors.forename: C
authors.initials: C
authors.lastname: Zwingelstein
authors.forename: A
authors.initials: A
authors.lastname: Rudler
authors.forename: A J
authors.initials: AJ
authors.lastname: Sleight
mesh_terms: D000661:Amphetamine / Q000037:antagonists & inhibitors / Q000494:pharmacology; D000818:Animals; D000697:Central Nervous System Stimulants / Q000037:antagonists & inhibitors / Q000494:pharmacology; D002831:Choroid Plexus / Q000187:drug effects / Q000378:metabolism; D003463:Cues; D004192:Discrimination, Psychological / Q000187:drug effects*; D005795:Generalization, Stimulus / Q000187:drug effects; D007211:Indoles / Q000494:pharmacology; D015544:Inositol 1,4,5-Trisphosphate / Q000096:biosynthesis; D008297:Male; D010879:Piperazines / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D011985:Receptors, Serotonin / Q000187:drug effects*; D012702:Serotonin Antagonists / Q000494:pharmacology; D017366:Serotonin Receptor Agonists / Q000494:pharmacology*; D014508:Urea / Q000031:analogs & derivatives / Q000494:pharmacology
chemical_list: D000697:Central Nervous System Stimulants; D007211:Indoles; D010879:Piperazines; D011985:Receptors, Serotonin; D012702:Serotonin Antagonists; D017366:Serotonin Receptor Agonists; C080864:N-(1-methyl-5-indolyl)-N'-(3-pyridyl)urea; D015544:Inositol 1,4,5-Trisphosphate; D014508:Urea; D000661:Amphetamine; C015068:1-(3-chlorophenyl)piperazine